Home > Healthcare > Drug Device Combination > Drug Filled Devices > Antidiabetics Market

Antidiabetics Market Share

  • Report ID: GMI504
  • Published Date: Jun 2020
  • Report Format: PDF

Antidiabetics Market Share

Some of the prominent business players operating in the antidiabetics industry share include:

  • AstraZeneca
  • Novartis AG
  • Johnson & Johnson
  • Merck & Co. Inc
  • Pfizer 
  • Sanofi

These market players are adopting various inorganic growth strategies to increase market share and achieve competitive advantage.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of antidiabetics exceeded USD 65.5 million in 2019.

The industry share of antidiabetics is expected to witness growth at over 10.7% CAGR from 2020 to 2026.

U.S. market will grow at 10.3% CAGR through 2026, says this GMI report.

Insulin market constituted significant industry share in 2019 and is expected to proceed at 12.4% CAGR up to 2026.

Insulin pump segment is forecast to progress at over 11% CAGR during the forecast years.

Some of the prominent business players operating in the antidiabetics industry include AstraZeneca, Novartis AG, Johnson & Johnson, Merck & Co. Inc., Pfizer and Sanofi.

Antidiabetics Market Scope

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Base Year: 2019
  • Companies covered: 14
  • Tables & Figures: 276
  • Countries covered: 15
  • Pages: 202
 Download Free Sample